SCHEDULE 13G

Company

GALECTIN THERAPEUTICS INC

Filed

February 4, 2002

Accession Number

0000891554-02-000391

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →